Loading…

Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response

•Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent chal...

Full description

Saved in:
Bibliographic Details
Published in:Veterinary microbiology 2017-02, Vol.199, p.91-99
Main Authors: Macedo, Nubia, Cheeran, Maxim C.J., Rovira, Albert, Holtcamp, Andrew, Torremorell, Montserrat
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3
cites cdi_FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3
container_end_page 99
container_issue
container_start_page 91
container_title Veterinary microbiology
container_volume 199
creator Macedo, Nubia
Cheeran, Maxim C.J.
Rovira, Albert
Holtcamp, Andrew
Torremorell, Montserrat
description •Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent challenge.•Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use. Haemophilus parasuis, the causative agent of Glasser’s disease, is a pathogen that colonizes the upper respiratory tract (URT) of pigs, invades the bloodstream and causes polyserositis. Because antimicrobials are highly effective against H. parasuis, we hypothesized that they could have a detrimental effect on the establishment of an immune response if given at the time of URT colonization. In this study, we characterized clinical outcomes and antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before or after low dose inoculation with a pathogenic H. parasuis strain. Pigs that were only inoculated with the agent (EXP group) and pigs that were treated with enrofloxacin and then inoculated (ABT/EXP group) developed signs of disease starting at 4days post inoculation (DPI), presented a significant increase in serum IgG and were protected against a subsequent homologous challenge. In contrast, pigs treated with antibiotic after inoculation (EXP/ABT group) neither showed signs of disease nor seroconverted (IgG) after low dose inoculation. EXP/ABT pigs as well as naïve control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to challenge. Variable levels of antibodies in bronchioalveolar fluid and IFN-γ in peripheral blood mononuclear cells were observed after H. parasuis inoculation, but were not associated with protection. In summary, only pigs treated before low dose H. parasuis inoculation seroconverted and were protected against subsequent challenge. Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.
doi_str_mv 10.1016/j.vetmic.2016.12.032
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1861594416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378113516302942</els_id><sourcerecordid>1963135618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVJaTZp_0Epglx6qF2NPmz5UghhmwQCvTRnocgjqsWWXGkdkn9fLZv20ENOw8DzzsdDyEdgLTDovu7aR9zPwbW8di3wlgn-hmxA96LhSvITsmGi1w2AUKfkrJQdY0wOHXtHTrkGYP3AN-R-6z26PU2eYszJT-nJuhBpivTG4pyWX2FaC11stmUNhYZ4wEOKX-gYCtqC1MaRhnleI9KMZUmx4Hvy1tup4IeXek7uv29_Xt00dz-ub68u7xqnGN83vQAhJB-8G5hFZkcuuR5G5ZTv5SA7L5zWWnnFerQoeQ-eaXQP2iPWT6w4J5-Pc5ecfq9Y9mYOxeE02YhpLQZ0B2qQErqKXvyH7tKaY73OwNDVQ1QHulLySLmcSsnozZLDbPOzAWYO2s3OHLWbg3YD3FTtNfbpZfj6MOP4L_TXcwW-HQGsNh4DZlNcwOhwDLn6NGMKr2_4A63LlQg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1963135618</pqid></control><display><type>article</type><title>Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response</title><source>ScienceDirect Journals</source><creator>Macedo, Nubia ; Cheeran, Maxim C.J. ; Rovira, Albert ; Holtcamp, Andrew ; Torremorell, Montserrat</creator><creatorcontrib>Macedo, Nubia ; Cheeran, Maxim C.J. ; Rovira, Albert ; Holtcamp, Andrew ; Torremorell, Montserrat</creatorcontrib><description>•Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent challenge.•Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use. Haemophilus parasuis, the causative agent of Glasser’s disease, is a pathogen that colonizes the upper respiratory tract (URT) of pigs, invades the bloodstream and causes polyserositis. Because antimicrobials are highly effective against H. parasuis, we hypothesized that they could have a detrimental effect on the establishment of an immune response if given at the time of URT colonization. In this study, we characterized clinical outcomes and antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before or after low dose inoculation with a pathogenic H. parasuis strain. Pigs that were only inoculated with the agent (EXP group) and pigs that were treated with enrofloxacin and then inoculated (ABT/EXP group) developed signs of disease starting at 4days post inoculation (DPI), presented a significant increase in serum IgG and were protected against a subsequent homologous challenge. In contrast, pigs treated with antibiotic after inoculation (EXP/ABT group) neither showed signs of disease nor seroconverted (IgG) after low dose inoculation. EXP/ABT pigs as well as naïve control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to challenge. Variable levels of antibodies in bronchioalveolar fluid and IFN-γ in peripheral blood mononuclear cells were observed after H. parasuis inoculation, but were not associated with protection. In summary, only pigs treated before low dose H. parasuis inoculation seroconverted and were protected against subsequent challenge. Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.</description><identifier>ISSN: 0378-1135</identifier><identifier>EISSN: 1873-2542</identifier><identifier>DOI: 10.1016/j.vetmic.2016.12.032</identifier><identifier>PMID: 28110792</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Anti-Bacterial Agents - administration &amp; dosage ; Antibiotics ; Antibodies, Bacterial - blood ; Antimicrobial agents ; Bacterial infections ; Colonization ; Enrofloxacin ; Female ; Fluoroquinolones - administration &amp; dosage ; Glasser's disease ; Group dynamics ; Haemophilus ; Haemophilus Infections - drug therapy ; Haemophilus Infections - immunology ; Haemophilus Infections - veterinary ; Haemophilus parasuis ; Haemophilus parasuis - immunology ; Homology ; Immune response ; Immunity ; Immunity (Disease) ; Immunoglobulin G ; Inoculation ; Interferon ; Interferon-gamma - blood ; Leukocytes (mononuclear) ; Male ; Peripheral blood mononuclear cells ; Polyserositis ; Random Allocation ; Respiratory tract ; Swine ; Swine Diseases - drug therapy ; Swine Diseases - immunology ; Time Factors</subject><ispartof>Veterinary microbiology, 2017-02, Vol.199, p.91-99</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV Feb 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3</citedby><cites>FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28110792$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Macedo, Nubia</creatorcontrib><creatorcontrib>Cheeran, Maxim C.J.</creatorcontrib><creatorcontrib>Rovira, Albert</creatorcontrib><creatorcontrib>Holtcamp, Andrew</creatorcontrib><creatorcontrib>Torremorell, Montserrat</creatorcontrib><title>Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response</title><title>Veterinary microbiology</title><addtitle>Vet Microbiol</addtitle><description>•Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent challenge.•Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use. Haemophilus parasuis, the causative agent of Glasser’s disease, is a pathogen that colonizes the upper respiratory tract (URT) of pigs, invades the bloodstream and causes polyserositis. Because antimicrobials are highly effective against H. parasuis, we hypothesized that they could have a detrimental effect on the establishment of an immune response if given at the time of URT colonization. In this study, we characterized clinical outcomes and antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before or after low dose inoculation with a pathogenic H. parasuis strain. Pigs that were only inoculated with the agent (EXP group) and pigs that were treated with enrofloxacin and then inoculated (ABT/EXP group) developed signs of disease starting at 4days post inoculation (DPI), presented a significant increase in serum IgG and were protected against a subsequent homologous challenge. In contrast, pigs treated with antibiotic after inoculation (EXP/ABT group) neither showed signs of disease nor seroconverted (IgG) after low dose inoculation. EXP/ABT pigs as well as naïve control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to challenge. Variable levels of antibodies in bronchioalveolar fluid and IFN-γ in peripheral blood mononuclear cells were observed after H. parasuis inoculation, but were not associated with protection. In summary, only pigs treated before low dose H. parasuis inoculation seroconverted and were protected against subsequent challenge. Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Antibiotics</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antimicrobial agents</subject><subject>Bacterial infections</subject><subject>Colonization</subject><subject>Enrofloxacin</subject><subject>Female</subject><subject>Fluoroquinolones - administration &amp; dosage</subject><subject>Glasser's disease</subject><subject>Group dynamics</subject><subject>Haemophilus</subject><subject>Haemophilus Infections - drug therapy</subject><subject>Haemophilus Infections - immunology</subject><subject>Haemophilus Infections - veterinary</subject><subject>Haemophilus parasuis</subject><subject>Haemophilus parasuis - immunology</subject><subject>Homology</subject><subject>Immune response</subject><subject>Immunity</subject><subject>Immunity (Disease)</subject><subject>Immunoglobulin G</subject><subject>Inoculation</subject><subject>Interferon</subject><subject>Interferon-gamma - blood</subject><subject>Leukocytes (mononuclear)</subject><subject>Male</subject><subject>Peripheral blood mononuclear cells</subject><subject>Polyserositis</subject><subject>Random Allocation</subject><subject>Respiratory tract</subject><subject>Swine</subject><subject>Swine Diseases - drug therapy</subject><subject>Swine Diseases - immunology</subject><subject>Time Factors</subject><issn>0378-1135</issn><issn>1873-2542</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kE1r3DAQhkVJaTZp_0Epglx6qF2NPmz5UghhmwQCvTRnocgjqsWWXGkdkn9fLZv20ENOw8DzzsdDyEdgLTDovu7aR9zPwbW8di3wlgn-hmxA96LhSvITsmGi1w2AUKfkrJQdY0wOHXtHTrkGYP3AN-R-6z26PU2eYszJT-nJuhBpivTG4pyWX2FaC11stmUNhYZ4wEOKX-gYCtqC1MaRhnleI9KMZUmx4Hvy1tup4IeXek7uv29_Xt00dz-ub68u7xqnGN83vQAhJB-8G5hFZkcuuR5G5ZTv5SA7L5zWWnnFerQoeQ-eaXQP2iPWT6w4J5-Pc5ecfq9Y9mYOxeE02YhpLQZ0B2qQErqKXvyH7tKaY73OwNDVQ1QHulLySLmcSsnozZLDbPOzAWYO2s3OHLWbg3YD3FTtNfbpZfj6MOP4L_TXcwW-HQGsNh4DZlNcwOhwDLn6NGMKr2_4A63LlQg</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Macedo, Nubia</creator><creator>Cheeran, Maxim C.J.</creator><creator>Rovira, Albert</creator><creator>Holtcamp, Andrew</creator><creator>Torremorell, Montserrat</creator><general>Elsevier B.V</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201702</creationdate><title>Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response</title><author>Macedo, Nubia ; Cheeran, Maxim C.J. ; Rovira, Albert ; Holtcamp, Andrew ; Torremorell, Montserrat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Antibiotics</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antimicrobial agents</topic><topic>Bacterial infections</topic><topic>Colonization</topic><topic>Enrofloxacin</topic><topic>Female</topic><topic>Fluoroquinolones - administration &amp; dosage</topic><topic>Glasser's disease</topic><topic>Group dynamics</topic><topic>Haemophilus</topic><topic>Haemophilus Infections - drug therapy</topic><topic>Haemophilus Infections - immunology</topic><topic>Haemophilus Infections - veterinary</topic><topic>Haemophilus parasuis</topic><topic>Haemophilus parasuis - immunology</topic><topic>Homology</topic><topic>Immune response</topic><topic>Immunity</topic><topic>Immunity (Disease)</topic><topic>Immunoglobulin G</topic><topic>Inoculation</topic><topic>Interferon</topic><topic>Interferon-gamma - blood</topic><topic>Leukocytes (mononuclear)</topic><topic>Male</topic><topic>Peripheral blood mononuclear cells</topic><topic>Polyserositis</topic><topic>Random Allocation</topic><topic>Respiratory tract</topic><topic>Swine</topic><topic>Swine Diseases - drug therapy</topic><topic>Swine Diseases - immunology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Macedo, Nubia</creatorcontrib><creatorcontrib>Cheeran, Maxim C.J.</creatorcontrib><creatorcontrib>Rovira, Albert</creatorcontrib><creatorcontrib>Holtcamp, Andrew</creatorcontrib><creatorcontrib>Torremorell, Montserrat</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Macedo, Nubia</au><au>Cheeran, Maxim C.J.</au><au>Rovira, Albert</au><au>Holtcamp, Andrew</au><au>Torremorell, Montserrat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response</atitle><jtitle>Veterinary microbiology</jtitle><addtitle>Vet Microbiol</addtitle><date>2017-02</date><risdate>2017</risdate><volume>199</volume><spage>91</spage><epage>99</epage><pages>91-99</pages><issn>0378-1135</issn><eissn>1873-2542</eissn><abstract>•Enrofloxacin treatment before low dose H. parasuis inoculation did not interfere with H. parasuis infection, subsequent seroconversion, and protection against challenge.•Pigs treated with enrofloxacin after low dose H. parasuis inoculation did not seroconvert and were susceptible to subsequent challenge.•Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use. Haemophilus parasuis, the causative agent of Glasser’s disease, is a pathogen that colonizes the upper respiratory tract (URT) of pigs, invades the bloodstream and causes polyserositis. Because antimicrobials are highly effective against H. parasuis, we hypothesized that they could have a detrimental effect on the establishment of an immune response if given at the time of URT colonization. In this study, we characterized clinical outcomes and antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before or after low dose inoculation with a pathogenic H. parasuis strain. Pigs that were only inoculated with the agent (EXP group) and pigs that were treated with enrofloxacin and then inoculated (ABT/EXP group) developed signs of disease starting at 4days post inoculation (DPI), presented a significant increase in serum IgG and were protected against a subsequent homologous challenge. In contrast, pigs treated with antibiotic after inoculation (EXP/ABT group) neither showed signs of disease nor seroconverted (IgG) after low dose inoculation. EXP/ABT pigs as well as naïve control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to challenge. Variable levels of antibodies in bronchioalveolar fluid and IFN-γ in peripheral blood mononuclear cells were observed after H. parasuis inoculation, but were not associated with protection. In summary, only pigs treated before low dose H. parasuis inoculation seroconverted and were protected against subsequent challenge. Results from this study can help determine timing of antimicrobial use and contribute to our current understanding of judicious antibiotic use.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28110792</pmid><doi>10.1016/j.vetmic.2016.12.032</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0378-1135
ispartof Veterinary microbiology, 2017-02, Vol.199, p.91-99
issn 0378-1135
1873-2542
language eng
recordid cdi_proquest_miscellaneous_1861594416
source ScienceDirect Journals
subjects Animals
Anti-Bacterial Agents - administration & dosage
Antibiotics
Antibodies, Bacterial - blood
Antimicrobial agents
Bacterial infections
Colonization
Enrofloxacin
Female
Fluoroquinolones - administration & dosage
Glasser's disease
Group dynamics
Haemophilus
Haemophilus Infections - drug therapy
Haemophilus Infections - immunology
Haemophilus Infections - veterinary
Haemophilus parasuis
Haemophilus parasuis - immunology
Homology
Immune response
Immunity
Immunity (Disease)
Immunoglobulin G
Inoculation
Interferon
Interferon-gamma - blood
Leukocytes (mononuclear)
Male
Peripheral blood mononuclear cells
Polyserositis
Random Allocation
Respiratory tract
Swine
Swine Diseases - drug therapy
Swine Diseases - immunology
Time Factors
title Effect of enrofloxacin on Haemophilus parasuis infection, disease and immune response
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T17%3A24%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20enrofloxacin%20on%20Haemophilus%20parasuis%20infection,%20disease%20and%20immune%20response&rft.jtitle=Veterinary%20microbiology&rft.au=Macedo,%20Nubia&rft.date=2017-02&rft.volume=199&rft.spage=91&rft.epage=99&rft.pages=91-99&rft.issn=0378-1135&rft.eissn=1873-2542&rft_id=info:doi/10.1016/j.vetmic.2016.12.032&rft_dat=%3Cproquest_cross%3E1963135618%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c502t-73133429fc90ae0ad24289d5c5f74946f3c8885f507eae4271f08ecb8fee496a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1963135618&rft_id=info:pmid/28110792&rfr_iscdi=true